Anne Wojtusciszyn

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


163 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
2023
 
Place de la pompe à insuline pour le traitement des patients avec un diabète de type 2 [Place of the insulin pump for the treatment of type 2 diabetic patients]
Deschamps A., Wojtusciszyn A., 2023/05/31. Revue medicale suisse, 19 (829) pp. 1066-1071. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D389F3B73AA8]
 
Traitement du diabète de type 2 : et si nous revenions à l’essentiel ?
Jornayvaz F.R., Wojtusciszyn A., 2023/05/31. Revue medicale suisse, 19 (829) pp. 1063-1064. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4F0B495469A1]
 
Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped.
Tariq M., de Souza A.H., Bensellam M., Chae H., Jaffredo M., Close A.F., Deglasse J.P., Santos LRB, Buemi A., Mourad N.I. et al., 2023/04. Diabetologia, 66 (4) pp. 709-723. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_55C0CB594B1F]
 
Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors.
Fontcuberta-PiSunyer M., García-Alamán A., Prades È., Téllez N., Alves-Figueiredo H., Ramos-Rodríguez M., Enrich C., Fernandez-Ruiz R., Cervantes S., Clua L. et al., 2023/03/24. Communications biology, 6 (1) p. 256. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A7D2FA870A37]
2022
 
Traitement de l’insuffisance cardiaque chez la personne âgée et inhibiteurs du SGLT2 - En avoir le cœur net [Treatment of congestive heart failure in older persons and SGLT2 inhibitors - Having your patient's best interests at heart]
Cleary D., Hannou S., Quiaios L., Monney P., Hullin R., Wojtusciszyn A., Büla C., Nguyen S., 2022/11/02. Revue medicale suisse, 18 (802) pp. 2057-2062. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_80827B6B8E66]
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.
Hepprich M., Mudry J.M., Gregoriano C., Jornayvaz F.R., Carballo S., Wojtusciszyn A., Bart P.A., Chiche J.D., Fischli S., Baumgartner T. et al., 2022/11. EClinicalMedicine, 53 p. 101649. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9319C60420A1]
Real world hypoglycaemia related to glucose variability and Flash glucose scan frequency assessed from global FreeStyle Libre data.
Riveline J.P., Wojtusciszyn A., Guerci B., Alves C., Kao K., Xu Y., Dunn T.C., 2022/11. Diabetes, obesity & metabolism, 24 (11) pp. 2102-2107. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EA178B988F35]
Insulines rapides et ultrarapides : quelles indications et utilités ? [Rapid and ultrarapid insulins: when and how?]
Vuignier Y., Wojtusciszyn A., Kosinski C., 2022/06/01. Revue medicale suisse, 18 (784) pp. 1110-1114. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8425169953DF]
Mesure continue du glucose - Rôles respectifs des personnels de santé et guide d’interprétation rapide [Continuous glucose monitoring Respective roles of healthcare professionals and quick interpretation guide]
Lutula J., Lamine F., Andrey M., Galfetti L., Wojtusciszyn A., 2022/06/01. Revue medicale suisse, 18 (784) pp. 1116-1122. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0999C8425A1B]
2021
 
Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network.
Lablanche S., Borot S., Wojtusciszyn A., Skaare K., Penfornis A., Malvezzi P., Badet L., Thivolet C., Morelon E., Buron F. et al., 2021/11. American journal of transplantation, 21 (11) pp. 3725-3733. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15730683B2AF]
Suivi clinique et paraclinique du diabète - Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique
Arditi C., Coendoz S., Labud H., Wojtusciszyn A., Peytremann-Bridevaux I., 2021/10/20. Revue medicale suisse, 17 (755) p. 1804. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_361DD7BDA286]
 
LDHA is enriched in human islet alpha cells and upregulated in type 2 diabetes.
Sanchez PKM, Khazaei M., Gatineau E., Geravandi S., Lupse B., Liu H., Dringen R., Wojtusciszyn A., Gilon P., Maedler K. et al., 2021/09/03. Biochemical and biophysical research communications, 568 pp. 158-166. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_913C1F9941F9]
Alimentation et diabète - Prise en charge multidisciplinaire du diabète : recommandations pour la pratique clinique.
Arditi C., Coendoz S., Kehl C., Labud H., Wojtusciszyn A., Peytremann-Bridevaux I., 2021/09/01. Revue medicale suisse, 17 (748) p. 1481. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_20A8B229605C]
Diabète secondaire aux nouvelles thérapies ciblées contre le cancer [New-onset diabetes and novel targeted therapies against cancer]
Zordan A., Kosinski C., Zaman K., Wojtusciszyn A., 2021/06/02. Revue medicale suisse, 17 (741) pp. 1067-1071. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F6604A18413C]
Insulinothérapie basale chez les patients diabétiques de type 2 [Basal insulin therapy in patients with type 2 diabetes]
Vuignier Y., Roukain A., Kosinski C., Wojtusciszyn A., 2021/06/02. Revue medicale suisse, 17 (741) pp. 1078-1082. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_52AF0A9A103F]
Le diabète : une pandémie oubliée ? []
Jornayvaz F.R., Wojtusciszyn A., 2021/06/02. Revue medicale suisse, 17 (741) pp. 1059-1060. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5758564A9ABB]
SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review.
Lu H., Lu H., Kosinski C., Wojtusciszyn A., Zanchi A., Carron P.N., Müller M., Meyer P., Martin J., Muller O. et al., 2021/05/10. Journal of clinical medicine, 10 (9) p. 2036. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D78919AA8999]
 
Impact of ischemia time on islet isolation success and posttransplantation outcomes: A retrospective study of 452 pancreas isolations
Wassmer C. H., Perrier Q., Combescure C., Pernin N., Parnaud G., Cottet-Dumoulin D., Brioudes E., Bellofatto K., Lebreton F., Berishvili E. et al., 2021/04. American Journal of Transplantation, 21 (4) pp. 1493-1502.
[DOI][WoS][serval:BIB_49C9FE7B602A]
 
Impact of ischemia time on islet isolation success and posttransplantation outcomes: A retrospective study of 452 pancreas isolations
Wassmer C. H., Perrier Q., Combescure C., Pernin N., Parnaud G., Cottet-Dumoulin D., Brioudes E., Bellofatto K., Lebreton F., Berishvili E. et al., 2021/04. Am J Transplant, 21 (4) pp. 1493-1502.
[DOI][Pmid][serval:BIB_6F9AD8B7C22A]
2020
Precision medicine in the era of artificial intelligence: implications in chronic disease management.
Subramanian M., Wojtusciszyn A., Favre L., Boughorbel S., Shan J., Letaief K.B., Pitteloud N., Chouchane L., 2020/12/09. Journal of translational medicine, 18 (1) p. 472. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_957F17DE7BED]
SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans.
Chae H., Augustin R., Gatineau E., Mayoux E., Bensellam M., Antoine N., Khattab F., Lai B.K., Brusa D., Stierstorfer B. et al., 2020/12. Molecular metabolism, 42 p. 101071. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1E550F2F51F8]
Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells.
Fernandez-Ruiz R., García-Alamán A., Esteban Y., Mir-Coll J., Serra-Navarro B., Fontcuberta-PiSunyer M., Broca C., Armanet M., Wojtusciszyn A., Kram V. et al., 2020/11/25. Nature communications, 11 (1) p. 5982. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5193C3AD9295]
 
The circadian clock nuclear receptor Rev-erb alpha is implicated in autophagy alteration and beta cell deficit under diabetogenic conditions
Costes S., Laouteouet D., Ravier M., Delobel M., Bertrand G., Villard O., Broca C., Mathieu J., Wojtusciszyn A., Dalle S. et al., 2020/09. Diabetologia, 63 (Suppl 1) pp. S48-S48.
[WoS][serval:BIB_D09DAF41AEC3]
 
Differential sensitivity of human islets from obese versus lean donors to chronic high glucose or palmitate
Castex F., Leroy J., Broca C., Mezghenna K., Duranton F., Lavallard V., Lebreton F., Gross R., Wojtusciszyn A., Lajoix A. D., 2020/07. J Diabetes, 12 (7) pp. 532-541.
[DOI][Pmid][serval:BIB_0F8F92DBC03A]
 
Differential sensitivity of human islets from obese versus lean donors to chronic high glucose or palmitate
Castex F., Leroy J., Broca C., Mezghenna K., Duranton F., Lavallard V., Lebreton F., Gross R., Wojtusciszyn A., Lajoix A. D., 2020/07. Journal of Diabetes, 12 (7) pp. 532-541.
[DOI][WoS][serval:BIB_994D23F7CD0D]
Diabète : et si on se mettait à la place du patient? []
Wojtusciszyn A., Jornayvaz F.R., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1183-1184. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C02B9D4BEF59]
Diabète post-transplantation rénale: le point de vue du diabétologue [Post-transplantation diabetes in kidney transplant: from the diabetologist point of view]
Pauchet A., Schwotzer N., Lamine F., Perrottet N., Zanchi A., Golshayan D., Wojtusciszyn A., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1200-1205. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_77E6105192BB]
Traitement par pompe à insuline : pour qui et comment le mettre en place en ambulatoire ? [Insulin pump treatment: For whom and how to set it up on an outpatient?]
Mbundu Ilunga R., Camponovo C., Le Dizès O., Wojtusciszyn A., 2020/06/10. Revue medicale suisse, 16 (697) pp. 1191-1196. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_434209D26400]
Diabète et infection à COVID-19 [Diabetes and COVID-19 infection]
Kosinski C., Zanchi A., Wojtusciszyn A., 2020/05/06. Revue medicale suisse, 16 (692) pp. 939-943. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_95589746FAF8]
Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features.
Villard O., Armanet M., Couderc G., Bony C., Moreaux J., Noël D., DeVos J., Klein B., Veyrune J.L., Wojtusciszyn A., 2020/04/17. Stem cell research & therapy, 11 (1) p. 158. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_BD54883E8A85]
 
Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using a Mixture of Metrics
Zheng F., Jalbert M., Forbes F., Bonnet S., Wojtusciszyn A., Lablanche S., Benhamou P. Y., 2020/04. Diabetes Technol Ther, 22 (4) pp. 301-313.
[DOI][Pmid][serval:BIB_1E280DECD001]
 
Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Monnier L., Wojtusciszyn A., Molinari N., Colette C., Renard E., Owens D., 2020/04. Diabetes care, 43 (4) pp. 821-827. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F453A394237D]
Traitement du diabète de type 2 avant, pendant et après la chirurgie métabolique [Treatment of type 2 diabetes before, during and after metabolic surgery]
Camponovo C., Wojtusciszyn A., Gilet P., Favre L., 2020/03/25. Revue medicale suisse, 16 (687) pp. 582-585.
[URN][DOI][Pmid][serval:BIB_C30B81FAC6D1]
 
Glycemic variability indices can be used to diagnose islet transplantation success in type 1 diabetic patients
Jalbert M., Zheng F., Wojtusciszyn A., Forbes F., Bonnet S., Skaare K., Benhamou P. Y., Lablanche S., Lablanche S., Lablanche S. et al., 2020/03. Acta Diabetologica, 57 (3) pp. 335-345.
[DOI][WoS][serval:BIB_62F92F1AC494]
 
Glycemic variability indices can be used to diagnose islet transplantation success in type 1 diabetic patients
Jalbert M., Zheng F., Wojtusciszyn A., Forbes F., Bonnet S., Skaare K., Benhamou P. Y., Lablanche S., Trimeco Study Group, 2020/03. Acta Diabetol, 57 (3) pp. 335-345.
[DOI][Pmid][serval:BIB_031FC5E93427]
 
Characterization of Daily Glycemic Variability in Subjects with Type 1 Diabetes Using a Mixture of Metrics
Zheng F., Jalbert M., Forbes F., Bonnet S., Wojtusciszyn A., Lablanche S., Benhamou P. Y., 2020. Diabetes Technology & Therapeutics, 22 (4) pp. 301-313.
[DOI][WoS][serval:BIB_EF9E61226D79]
 
Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features (vol 11, 158, 2020)
Villard O., Armanet M., Couderc G., Bony C., Moreaux J., Noel D., De Vos J., Klein B., Veyrune J. L., Wojtusciszyn A., 2020. Stem Cell Research & Therapy, 11 (1).
[WoS][serval:BIB_702B3467ECA5]
Correction to: Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features
Villard O., Armanet M., Couderc G., Bony C., Moreaux J., Noel D., De Vos J., Klein B., Veyrune J. L., Wojtusciszyn A., 2020. Stem Cell Res Ther, 11 (1) p. 190.
[URN][DOI][Pmid][serval:BIB_CEF5AA3F100B]
 
Rétinopathie diabétique Recommandations pour la pratique clinique
Konstantinidis Lazaros, Ambresin Aude, Wojtusciszyn Anne, 2020/01..
[serval:BIB_442B92992ADB]
2019
 
Faut-il dépister l’artériopathie oblitérante des membres inférieurs chez les patients avec diabète de type [Should patients with type 2 diabetes be screened for lower extremity arterial disease?]
Buso G., Collet T.H., Wojtusciszyn A., Maufus M., Ney B., Mazzolai L., 2019/12/04. Revue medicale suisse, 15 (674) pp. 2236-2240. Peer-reviewed.
[Pmid][serval:BIB_43423B602163]
 
Opposite functions of beta-arrestin2 for the potentiation of insulin secretion by GLP-1 and GIP
Ravier M., Obeid J., Costes S., Leduc M., Broca C., Wojtusciszyn A., Dalle S., Bertrand G., 2019/09. Diabetologia, 62 pp. S213-S213.
[WoS][serval:BIB_BB6D0367FB66]
 
SGLT2 is not expressed in pancreatic alpha and beta cells and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans
Gilon P., Chae H., Antoine N., Lai B. K., Singh B., Ruiz L., Wojtusciszyn A., Broca C., Stierstorfer B., Klein H. et al., 2019/09. Diabetologia, 62 pp. S125-S125.
[WoS][serval:BIB_41AD17F18437]
 
The conditioned medium of human immortalised pancreatic stromal cells: a favourable supportive microenvironment for human beta cell
Villard O., Chiang Y. H., Sabatier J., Broca C., Cattan P., Wojtusciszyn A., Armanet M., 2019/09. Diabetologia, 62 pp. S199-S200.
[WoS][serval:BIB_F31DED08ADA9]
 
Targeting pancreatic islet PTP1B improves islet graft revascularization and transplant outcomes.
Figueiredo H., Figueroa ALC, Garcia A., Fernandez-Ruiz R., Broca C., Wojtusciszyn A., Malpique R., Gasa R., Gomis R., 2019/06/19. Science translational medicine, 11 (497). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_48A462F9F97E]
 
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
Bosi E., Choudhary P., de Valk H. W., Lablanche S., Castaneda J., de Portu S., Da Silva J., Re R., Vorrink-de Groot L., Shin J. et al., 2019/06. Lancet Diabetes & Endocrinology, 7 (6) pp. 462-472.
[DOI][WoS][serval:BIB_D60CB739290D]
 
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Societe francophone du diabete (SFD), Societe francaise d'endocrinologie (SFE), Societe francophone de transplantation (SFT) and Societe francaise de nephrologie - dialyse - transplantation (SFNDT)
Wojtusciszyn A., Branchereau J., Esposito L., Badet L., Buron F., Chetboun M., Kessler L., Morelon E., Berney T., Pattou F. et al., 2019/06. Diabetes Metab, 45 (3) pp. 224-237.
[DOI][Pmid][serval:BIB_A1A57582177C]
 
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Societe francophone du diabete (SFD), Societe francaise d'endocrinologie (SFE), Societe francophone de transplantation (SFT) and Societe francaise de nephrologie - dialyse - transplantation (SFNDT)
Wojtusciszyn A., Branchereau J., Esposito L., Badet L., Buron F., Chetboun M., Kessler L., Morelon E., Berney T., Pattou F. et al., 2019/06. Diabetes & Metabolism, 45 (3) pp. 224-237.
[DOI][WoS][serval:BIB_D98F74A2081C]
2018
 
Proteasomal degradation of the histone acetyl transferase p300 contributes to beta cell injury in a diabetes environment
Costes S., Ruiz L., Gurlo T., Ravier M. A., Wojtusciszyn A., Mathieu J., Brown M. R., Broca C., Bertrand G., Butler P. C. et al., 2018/10. Diabetologia, 61 pp. S188-S189.
[WoS][serval:BIB_A9CFD62C97A6]
 
Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes - a multi-centre cohort study
Meier R. P. H., Andrey D. O., Sun P., Niclauss N., Bedat B., Demuylder-Mischler S., Borot S., Benhamou P. Y., Wojtusciszyn A., Buron F. et al., 2018/08. Transplant International, 31 (8) pp. 917-929.
[DOI][WoS][serval:BIB_53416377EB0B]
 
Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes - a multi-centre cohort study
Meier R. P. H., Andrey D. O., Sun P., Niclauss N., Bedat B., Demuylder-Mischler S., Borot S., Benhamou P. Y., Wojtusciszyn A., Buron F. et al., 2018/08. Transpl Int, 31 (8) pp. 917-929.
[DOI][Pmid][serval:BIB_060FEC04BF3D]
 
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
Lablanche S., Vantyghem M. C., Kessler L., Wojtusciszyn A., Borot S., Thivolet C., Girerd S., Bosco D., Bosson J. L., Colin C. et al., 2018/07. Lancet Diabetes & Endocrinology, 6 (7) pp. 527-537.
[DOI][WoS][serval:BIB_53AB03A87E08]
 
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
Lablanche S., Vantyghem M. C., Kessler L., Wojtusciszyn A., Borot S., Thivolet C., Girerd S., Bosco D., Bosson J. L., Colin C. et al., 2018/07. Lancet Diabetes Endocrinol, 6 (7) pp. 527-537.
[DOI][Pmid][serval:BIB_6144B225F247]
 
The Second Phase of Insulin Secretion in Nondiabetic Islet-Grafted Recipients Is Altered and Can Predict Graft Outcome
Villard O., Brun J. F., Bories L., Molinari N., Benhamou P. Y., Berney T., Wojtusciszyn A., 2018/04. Journal of Clinical Endocrinology & Metabolism, 103 (4) pp. 1310-1319.
[DOI][WoS][serval:BIB_E01D73DA944C]
 
Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment
Ruiz L., Gurlo T., Ravier M. A., Wojtusciszyn A., Mathieu J., Brown M. R., Broca C., Bertrand G., Butler P. C., Matveyenko A. V. et al., 2018. Cell Death & Disease, 9.
[WoS][serval:BIB_91A24FC7CF15]
Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment
Ruiz L., Gurlo T., Ravier M. A., Wojtusciszyn A., Mathieu J., Brown M. R., Broca C., Bertrand G., Butler P. C., Matveyenko A. V. et al., 2018. Cell Death Dis, 9 (6) p. 600.
[URN][DOI][Pmid][serval:BIB_07427F5B73A3]
 
The Second Phase of Insulin Secretion in Nondiabetic Islet-Grafted Recipients Is Altered and Can Predict Graft Outcome
Villard O., Brun J. F., Bories L., Molinari N., Benhamou P. Y., Berney T., Wojtusciszyn A., 2018. J Clin Endocrinol Metab, 103 (4) pp. 1310-1319.
[DOI][Pmid][serval:BIB_BBC5A476A059]
2017
 
Comparaison of metabolic results and complications of procedures for pancreas or islet grafts in the two years following transplantation: a single centre experience
Villard O., Delmas S., Benhamou P., Berney T., Brun J., Mourad G., Pierredon M. A., Panaro F., Wojtusciszyn A., 2017/09. Diabetologia, 60 pp. S208-S208.
[WoS][serval:BIB_4DBA86B0B77D]
 
Contributing Factors and Impact of Microbial Contamination in Human Islet Isolation and Transplantation
Meier R., Andrey D., Niclauss N., Sun P., Van Delden C., Bedat B., Demuylder-Mischler S., Borot S., Benhamou P. Y., Wojtusciszyn A. et al., 2017/09. Transplant International, 30 pp. 353-353.
[WoS][serval:BIB_EBB8155C591D]
 
Degradation of the histone acetyl transferase p300 by the ubiquitin-proteasome pathway contributes to beta cell injury in type 2 diabetes environment
Costes S., Ruiz L., Wojtusciszyn A., Ravier M., Mathieu J., Bertrand G., Dalle S., 2017/09. Diabetologia, 60 pp. S179-S179.
[WoS][serval:BIB_F3CFB5EE7262]
 
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Monnier L., Colette C., Wojtusciszyn A., Dejager S., Renard E., Molinari N., Owens D. R., 2017/07. Diabetes Care, 40 (7) pp. 832-838.
[DOI][Pmid][serval:BIB_819F459AE3EF]
 
Contributing Factors and Impact of Microbial Contamination in Human Islet Isolation and Transplantation
Meier R., Andrey D., Niclauss N., Sun P., van Delden C., Bedat B., Demuylder-Mischler S., Borot S., Benhamou P. Y., Wojtusciszyn A. et al., 2017/04. American Journal of Transplantation, 17 pp. 693-693.
[WoS][serval:BIB_BB94B5F22A34]
 
Randomised, prospective, medicoeconomic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol
Lablanche S., David-Tchouda S., Margier J., Schir E., Wojtusciszyn A., Borot S., Kessler L., Morelon E., Thivolet C., Pattou F. et al., 2017/02. Bmj Open, 7 (2).
[WoS][serval:BIB_679AD81D6140]
 
Intraislet Glucagon-Like Peptide-1 Mediates GPR119 Agonist Insulinotropic Effect
Mathieu J., Bertrand G., Vallaghe J., Charriersavournin F., Gregor N., Vatel E., Wojtusciszyn A., Trinquet E., Ravier M., Dalle S., 2017. Diabetes, 66 pp. A29-A29.
[WoS][serval:BIB_C96B66C7EA65]
 
Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol
Lablanche S., David-Tchouda S., Margier J., Schir E., Wojtusciszyn A., Borot S., Kessler L., Morelon E., Thivolet C., Pattou F. et al., 2017. BMJ Open, 7 (2) pp. e013434.
[DOI][Pmid][serval:BIB_017B94E08AAE]
 
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Monnier L., Colette C., Wojtusciszyn A., Dejager S., Renard E., Molinari N., Owens D. R., 2017. Diabetes Care, 40 (7) pp. 832-838.
[DOI][WoS][serval:BIB_9300B538BB88]
2016
 
Mathematic analysis of meal tests to evaluate beta cell mass in islet-transplanted patients
Brun J. F. R., Villard O., Berney T., Benhamou P. Y., Wojtusciszyn A., 2016/08. Diabetologia, 59 pp. S120-S120.
[WoS][serval:BIB_A9DD9AC8B786]
 
Alloimmune Monitoring After Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients
Delaune V., Toso C., Benhamou P. Y., Wojtusciszyn A., Kessler L., Slits F., Demuylder-Mischler S., Pernin N., Lablanche S., Orci L. A. et al., 2016. Cell Transplant, 25 (12) pp. 2259-2268.
[DOI][Pmid][serval:BIB_C37CCEE3A8EF]
 
Alloimmune Monitoring After Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients
Delaune V., Toso C., Benhamou P. Y., Wojtusciszyn A., Kessler L., Slits F., Demuylder-Mischler S., Pernin N., Lablanche S., Orci L. A. et al., 2016. Cell Transplantation, 25 (12) pp. 2259-2268.
[DOI][WoS][serval:BIB_CAE69405260F]
 
Inhibition of the MAP3 kinase Tpl2 protects rodent and human beta-cells from apoptosis and dysfunction induced by cytokines and enhances anti-inflammatory actions of exendin-4
Varin E. M., Wojtusciszyn A., Broca C., Muller D., Ravier M. A., Ceppo F., Renard E., Tanti J. F., Dalle S., 2016/01. Cell Death & Disease, 7.
[WoS][serval:BIB_E100E34D7F6E]
 
Inhibition of the MAP3 kinase Tpl2 protects rodent and human beta-cells from apoptosis and dysfunction induced by cytokines and enhances anti-inflammatory actions of exendin-4
Varin E. M., Wojtusciszyn A., Broca C., Muller D., Ravier M. A., Ceppo F., Renard E., Tanti J. F., Dalle S., 2016. Cell Death Dis, 7 pp. e2065.
[DOI][Pmid][serval:BIB_FD59B76D2DA5]
2015
 
A Randomized, Prospective, Medico-Economic Nationwide French Study of Islet Transplantation in Patients with Type 1 Brittle Diabetes: The Stabilot Study Protocol
Lablanche S., David-Tchouda S., Borot S., Wojtusciszyn A., Margier J., Tetaz R., Badet L., Thivolet C., Buron F., Morelon E. et al., 2015/11. Transplant International, 28 pp. 469-469.
[WoS][serval:BIB_EE33E1671284]
 
The reference site of the European partnership of innovation for active aging and good health MACVIA-LR (against chronic diseases for healthy ageing in Languedoc-Roussillon)
Bourret R., Bousquet J., Camuzat T., Auge P., Domy P., Bringer J., Best N., Jonquet O., de la Coussaye J. E., Nogues M. et al., 2015/11. Presse Medicale, 44 pp. S6-S22.
[DOI][WoS][serval:BIB_093C6CDB1DCD]
 
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network
Lablanche S., Borot S., Wojtusciszyn A., Bayle F., Tetaz R., Badet L., Thivolet C., Morelon E., Frimat L., Penfornis A. et al., 2015/09. Diabetes Care, 38 (9) pp. 1714-22.
[DOI][Pmid][serval:BIB_57D3F71EDC78]
 
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network
Lablanche S., Borot S., Wojtusciszyn A., Bayle F., Tetaz R., Badet L., Thivolet C., Morelon E., Frimat L., Penfomis A. et al., 2015/09. Diabetes Care, 38 (9) pp. 1714-1722.
[DOI][WoS][serval:BIB_7F79E9CDE2EB]
 
Inhibition of Inflammation-induced Pancreatic Beta-Cell Failure by Targeting the MAP3 Kinase Tpl2: A Potential New Immunotherapy for Type 2 Diabetes
Varin E., Muller D., Broca C., Ravier M., Ceppo F., Renard E., Wojtusciszyn A., Tanti J. F., Dalle S., 2015/06. Diabetes, 64 pp. A575-A575.
[WoS][serval:BIB_9082304BDE33]
2014
 
Meal tests to assess beta cell function and mass in islet-transplanted patients
Brun J. F. R., Bories L., Berney T., Mercier J., Benhamou P. Y., Wojtusciszyn A., 2014/09. Diabetologia, 57 pp. S200-S200.
[WoS][serval:BIB_53E6393B94EF]
 
Acute nutrient regulation of the mitochondrial glutathione redox state in pancreatic beta-cells
Takahashi H. K., Santos L. R., Roma L. P., Duprez J., Broca C., Wojtusciszyn A., Jonas J. C., 2014. Biochem J, 460 (3) pp. 411-23.
[DOI][Pmid][serval:BIB_130B9154798D]
 
Acute nutrient regulation of the mitochondrial glutathione redox state in pancreatic beta-cells
Takahashi H. K., Santos L. R. B., Roma L. P., Duprez J., Broca C., Wojtusciszyn A., Jonas J. C., 2014. Biochemical Journal, 460 pp. 411-423.
[DOI][WoS][serval:BIB_D52B01F18BEF]
 
Impact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network
Lablanche S., Borot S., Thaunat O., Bayle F., Badet L., Morelon E., Thivolet C., Wojtusciszyn A., Frimat L., Kessler L. et al., 2014. Transplantation, 98 (4) pp. 475-82.
[DOI][Pmid][serval:BIB_80E324A62CB0]
 
Impact of Anti-Insulin Antibodies on Islet Transplantation Outcome: Data From the GRAGIL Network
Lablanche S., Borot S., Thaunat O., Bayle F., Badet L., Morelon E., Thivolet C., Wojtusciszyn A., Frimat L., Kessler L. et al., 2014. Transplantation, 98 (4) pp. 475-482.
[DOI][WoS][serval:BIB_BB38EEC807B5]
 
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets
Broca C., Varin E., Armanet M., Tourrel-Cuzin C., Bosco D., Dalle S., Wojtusciszyn A., 2014. Plos One, 9 (3).
[WoS][serval:BIB_C58A0A761F2C]
 
Proteasome dysfunction mediates high glucose-induced apoptosis in rodent beta cells and human islets
Broca C., Varin E., Armanet M., Tourrel-Cuzin C., Bosco D., Dalle S., Wojtusciszyn A., 2014. PLoS One, 9 (3) pp. e92066.
[DOI][Pmid][serval:BIB_FE5F43CB87B0]
 
Proteasome Dysfunction Mediates High Glucose-Induced Apoptosis in Rodent Beta Cells and Human Islets (vol 9, e92066, 2014)
Broca C., Varin E., Armanet M., Tourrel-Cuzin C., Bosco D., Dalle S., Wojtusciszyn A., 2014. Plos One, 9 (7).
[WoS][serval:BIB_B7FB8EE7E7D5]
 
Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies
Bousquet J., Jorgensen C., Dauzat M., Cesario A., Camuzat T., Bourret R., Best N., Anto J. M., Abecassis F., Aubas P. et al., 2014. Current Pharmaceutical Design, 20 (38) pp. 5928-5944.
[WoS][serval:BIB_05671F3E381C]
 
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies
Bousquet J., Jorgensen C., Dauzat M., Cesario A., Camuzat T., Bourret R., Best N., Anto J. M., Abecassis F., Aubas P. et al., 2014. Curr Pharm Des, 20 (38) pp. 5928-44.
[DOI][Pmid][serval:BIB_AE6B28456A67]
2013
 
Short-term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47(phox) subunit in monocytes from type 2 diabetes patients
Vaquer G., Magous R., Cros G., Wojtusciszyn A., Renard E., Chevassus H., Petit P., Lajoix A. D., Oiry C., 2013/12. Fundam Clin Pharmacol, 27 (6) pp. 669-71.
[DOI][Pmid][serval:BIB_24AB252A40E0]
 
Short-term intravenous insulin infusion is associated with reduced expression of NADPH oxidase p47(phox) subunit in monocytes from type 2 diabetes patients
Vaquer G., Magous R., Cros G., Wojtusciszyn A., Renard E., Chevassus H., Petit P., Lajoix A. D., Oiry C., 2013/12. Fundamental & Clinical Pharmacology, 27 (6) pp. 669-671.
[DOI][WoS][serval:BIB_9D3C2D6CD39E]
 
Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure
Wojtusciszyn A., Mourad G., Bringer J., Renard E., 2013/10. Diabetes Metab, 39 (5) pp. 404-10.
[DOI][Pmid][serval:BIB_51B8F044189B]
 
Differential role of NO in the control of insulin secretion in human pancreatic islets
Castex F., Chalancon A., Leroy J., Mezghenna K., Parnaud G., Wojtusciszyn A., Broca C., Bosco D., Gross R., Lajoix A. D., 2013/09. Diabetologia, 56 pp. S197-S198.
[WoS][serval:BIB_2FEF03E52D3A]
 
Isolation, Characterization and Hepatocyte Differentiation of Human Adult Progenitor Cells from Liver and Pancreas
Duret C., Iankova I., Ramos J., Gerbal-Chaloin S., Fabre J. M., Wojtusciszyn A., Maurel P., Daujat-Chavanieu M., 2013/04. Journal of Hepatology, 58 pp. S125-S125.
[WoS][serval:BIB_5F968857191A]
2012
 
Isolation, characterization and hepatocyte differentiation of human adult progenitor cells from liver and pancreas
Duret C., Iankova I., Ramos J., Gerbal-Chaloin S., Fabre J. M., Wojtusciszyn A., Maurel P., Daujat-Chavanieu M., 2012/10. Human Gene Therapy, 23 (10) pp. A86-A86.
[WoS][serval:BIB_476457C13D77]
 
Glucose favors pancreatic beta cell survival in inhibiting a constitutive apoptotic programme via the containment of CREB transcription factor expression
Varin E., Costes S., Broca C., Berney T., Renard E., Wojtusciszyn A., Dalle S., 2012/03. Diabetes & Metabolism, 38 pp. A72-A72.
[WoS][serval:BIB_6FB4D9D50DFF]
 
Comparative impact on islet isolation and transplant outcome of the preservation solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior
Niclauss N., Wojtusciszyn A., Morel P., Demuylder-Mischler S., Brault C., Parnaud G., Ris F., Bosco D., Badet L., Benhamou P. Y. et al., 2012. Transplantation, 93 (7) pp. 703-8.
[DOI][Pmid][serval:BIB_B09A00A6B4B0]
 
Comparative Impact on Islet Isolation and Transplant Outcome of the Preservation Solutions Institut Georges Lopez-1, University of Wisconsin, and Celsior
Niclauss N., Wojtusciszyn A., Morel P., Demuylder-Mischler S., Brault C., Parnaud G., Ris F., Bosco D., Badet L., Benhamou P. Y. et al., 2012. Transplantation, 93 (7) pp. 703-708.
[DOI][WoS][serval:BIB_F2A7F6CE0F48]
 
Glycaemic Control and Variability in Type 1 Diabetic Patients With A1c Below 8% Treated by Insulin Pump is Better When Intra-Peritoneal Infusion is Chosen
Dupuis M. J., Ribotton M., Place J., Monnier L., Renard E., Wojtusciszyn A., 2012. Diabetes, 61 pp. A224-A225.
[WoS][serval:BIB_320BBABEA441]
2011
 
Towards an artificial pancreas at home
Renard E., Farret A., Place J., Wojtusciszyn A., Bringer J., 2011/12. Diabetes & Metabolism, 37 pp. S94-S98.
[WoS][serval:BIB_02858495A0AC]
 
Towards an artificial pancreas at home
Renard E., Farret A., Place J., Wojtusciszyn A., Bringer J., 2011/12. Diabetes Metab, 37 Suppl 4 pp. S94-8.
[DOI][Pmid][serval:BIB_7916087E4C8B]
 
Impact of the Number of Infusions on Two-Year Metabolic Results of Islet-after-Kidney Transplantation in the Gragil Network
Borot S., Niclauss N., Wojtusciszyn A., Brault C., Muller Y., Giovannoni L., Parnaud G., Meier R., Kessler L., Thivolet C. et al., 2011/09. Transplant International, 24 pp. 48-48.
[WoS][serval:BIB_6BDC795AD139]
 
The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes
Monnier L., Wojtusciszyn A., Colette C., Owens D., 2011/08. Diabetes Technol Ther, 13 (8) pp. 813-8.
[DOI][Pmid][serval:BIB_1FF1B2BB98D3]
 
The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 Diabetes
Monnier L., Wojtusciszyn A., Colette C., Owens D., 2011/08. Diabetes Technology & Therapeutics, 13 (8) pp. 813-818.
[DOI][WoS][serval:BIB_C6226F8C5131]
 
About an overdose: interest of o,p '-DDA and o,p '-DDE determination for the therapeutic drug monitoring of mitotane in adrenocortical carcinoma therapy
Mathieu O., Wojtusciszyn A., Raingeard I., Hillaire-Buys D., 2011/04. Fundamental & Clinical Pharmacology, 25 pp. 81-81.
[WoS][serval:BIB_EA878E6C6020]
 
Assessment of glycemic variability in patients with type 1 diabetes whose HbA1c is below 8% under insulin pump
Barbu I., Raingeard I., Chalancon A., Renard E., Bringer J., Wojtusciszyn A., 2011/03. Diabetes & Metabolism, 37 pp. A106-A106.
[WoS][serval:BIB_BE877CEFA514]
 
Evaluation of possible indications of the use of Langeran transplant in type 1 diabetes insufficiently controlled with an insulin pump
Leprieur E., Place J., Monnier L., Renard E., Wojtusciszyn A., 2011/03. Diabetes & Metabolism, 37 pp. A103-A103.
[WoS][serval:BIB_D26F0E90B4D9]
 
Impact of the number of grafts on the results of islet transplant after kidney
Borot S., Niclauss N., Brault C., Kessler L., Wojtusciszyn A., Thivolet C., Penfornis A., Badet L., Frimat L., Bayle F. et al., 2011/03. Diabetes & Metabolism, 37 pp. A20-A20.
[WoS][serval:BIB_085C0F7FAE29]
 
Glucose-Dependent Survival of Beta-Cells Is Achieved by Maintenance of Optimal CREB Expression Resulting in Suppression of Apoptosis
Costes S., Varin E., Broca C., Linck N., Wojtusciszyn A., Dalle S., 2011. Diabetes, 60 pp. A522-A522.
[WoS][serval:BIB_BDB4843FD112]
 
Impact of the Number of Infusions on 2-Year Results of Islet-After-Kidney Transplantation in the GRAGIL Network
Borot S., Niclauss N., Wojtusciszyn A., Brault C., Demuylder-Mischler S., Muller Y., Giovannoni L., Parnaud G., Meier R., Badet L. et al., 2011. Transplantation, 92 (9) pp. 1031-1038.
[DOI][WoS][serval:BIB_1FF9FBC5AE55]
 
Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network
Borot S., Niclauss N., Wojtusciszyn A., Brault C., Demuylder-Mischler S., Muller Y., Giovannoni L., Parnaud G., Meier R., Badet L. et al., 2011. Transplantation, 92 (9) pp. 1031-8.
[DOI][Pmid][serval:BIB_8D93A2CC6AE6]
2010
 
The rapid correction of chronic hyperglycemia with insulin reduces the expression of a subunit of NADPH oxidase in type 2 diabetics.
Vaquer G., Wojtusciszyn A., Renard E., Cros G., Magous R., Petit P., Lajoix A. D., Oiry C., 2010/03. Diabetes & Metabolism, 36 pp. A57-A57.
[WoS][serval:BIB_5D8C798E8297]
2009
 
Regulated laminin-332 expression in human islets of Langerhans
Armanet M., Wojtusciszyn A., Morel P., Parnaud G., Rousselle P., Sinigaglia C., Berney T., Bosco D., 2009/12. Faseb Journal, 23 (12) pp. 4046-4055.
[DOI][WoS][serval:BIB_2C87E7D766DB]
 
Regulated laminin-332 expression in human islets of Langerhans
Armanet M., Wojtusciszyn A., Morel P., Parnaud G., Rousselle P., Sinigaglia C., Berney T., Bosco D., 2009/12. FASEB J, 23 (12) pp. 4046-55.
[DOI][Pmid][serval:BIB_8D048E66BE49]
 
Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation
Wojtusciszyn A., Andres A., Morel P., Charvier S., Armanet M., Toso C., Choi Y., Bosco D., Berney T., 2009/09. Transplant International, 22 (9) pp. 931-939.
[DOI][WoS][serval:BIB_0E1D7A0A344D]
 
Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation
Wojtusciszyn A., Andres A., Morel P., Charvier S., Armanet M., Toso C., Choi Y., Bosco D., Berney T., 2009/09. Transpl Int, 22 (9) pp. 931-9.
[DOI][Pmid][serval:BIB_1118C8F3FF1A]
 
Improved metabolic control and quality of life in 10 patients with type 1 diabetes following islet after kidney transplantation: results of the GRAGIL 1 trial
Wojtusciszyn A., Brault C., Guittard-Millat L., Niklauss N., Badet L., Demuylder S., Penfornis A., Thivolet C., Colin C., Renard E. et al., 2009/09. Diabetologia, 52 pp. S189-S189.
[WoS][serval:BIB_5627F4C03EFE]
 
Investigation of features of type 2 diabetic patients with secondary failure to oral hypoglycaemic agents associated with blood glucose response to exenatide
Sardinoux M., Baptista G., Wojtusciszyn A., Bringer J., Renard E., 2009/09. Diabetologia, 52 pp. S287-S287.
[WoS][serval:BIB_AAACF571673E]
 
Comparative Impact on Islet Isolation and Transplantation Outcome of the New Preservation Solution Igl-1 Versus Uw and Celsior
Niclauss N., Wojtusciszyn A., Morel P., Demuylder-Mischler S., Brault C., Bosco D., Benhamou P. Y., Berney T., 2009/08. Transplant International, 22 pp. 141-141.
[WoS][serval:BIB_B85A3FA543AC]
 
Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials
Benhamou P. Y., Milliat-Guittard L., Wojtusciszyn A., Kessler L., Toso C., Baertschiger R., Debaty I., Badet L., Penfornis A., Thivolet C. et al., 2009/06. Diabetic Medicine, 26 (6) pp. 617-621.
[DOI][WoS][serval:BIB_5FA3F222A499]
 
Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials
Benhamou P. Y., Milliat-Guittard L., Wojtusciszyn A., Kessler L., Toso C., Baertschiger R., Debaty I., Badet L., Penfornis A., Thivolet C. et al., 2009/06. Diabet Med, 26 (6) pp. 617-21.
[DOI][Pmid][serval:BIB_E34DABEF544D]
 
Assessment of the metabolic and quality of life after pancreatic islet transplantation in diabetic patients with type 1 renal transplantation: results of the group Gragil
Wojtusciszyn A., Brault C., Niklauss N., Badet L., Renard E., Colin C., Thivolet C., Frimat L., Penfornis A., Berney T. et al., 2009/03. Diabetes & Metabolism, 35 pp. A10-A10.
[WoS][serval:BIB_263353D98973]
 
Comparative Impact on Islet Isolation and Transplantation Outcome of the New Preservation Solution IGL-1 Versus UW and Celsior.
Niclauss N., Wojtusciszyn A., Morel P., Demuylder-Mischler S., Brault C., Bosco D., Benhamou P. Y., Berney T., 2009. American Journal of Transplantation, 9 pp. 407-407.
[WoS][serval:BIB_32E14855B4D0]
 
Comparative impact on islet isolation and transplantation outcome of the new preservation solution IGL-1 vs UW and Celsior
Niclauss N., Wojtusciszyn A., Morel P., Demuylder-Mischler S., Brault C., Ris F., Parnaud G., Bosco D., Benhamou P. Y., Berney T., 2009. Xenotransplantation, 16 (5) pp. 320-+.
[WoS][serval:BIB_710C8ED01FFE]
2008
 
Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts
Wojtusciszyn A., Armanet M., Morel P., Berney T., Bosco D., 2008/10. Diabetologia, 51 (10) pp. 1843-1852.
[DOI][WoS][serval:BIB_180F1F73C2C4]
 
Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts
Wojtusciszyn A., Armanet M., Morel P., Berney T., Bosco D., 2008/10. Diabetologia, 51 (10) pp. 1843-52.
[DOI][Pmid][serval:BIB_9B39AFC6F19D]
 
Beneficial effects of IL-1ra on islet of langerhans mass and function in vivo
Wojtusciszyn A., Armanet M., Morel P., Nicklauss N., Charvier S., Bosco D., Berney T., 2008/06. Diabetes, 57 pp. A456-A456.
[WoS][serval:BIB_06404CEA12EF]
 
Results of 110 solitary islet transplantations in 66 type 1 diabetic patients in the Swiss-French GRAGIL consortium
Wojtusciszyn A., Milliat-Guittard L., Kessler L., Nicklauss N., Riss F., Badet L., Penformis A., Bayle F., Thivolet C., Bosco D. et al., 2008/06. Diabetes, 57 pp. A110-A110.
[WoS][serval:BIB_778DF9A2FC3A]
 
Depletion of macrophage migration inhibitory factor (MIF) improves islet engraftment and survival following transplantation
Toso C., Serre-Beinier V., Armanet M., Emamaullee J., Merani S., Wojtusciszyn A., Morel P., Bosco D., Berney T., Shapiro J. M., 2008/05. American Journal of Transplantation, 8 pp. 502-502.
[WoS][serval:BIB_3848E1F5C739]
 
1beta-interleukin improves laminin-5 expression in human pancreatic islets
Armanet M., Wojtusciszyn A., Morel P., Berney T., Bosco D., 2008/03. Diabetes & Metabolism, 34 pp. A54-A54.
[WoS][serval:BIB_BC1A358FA20A]
 
Computer-Assisted Digital Image Analysis to Quantify the Mass and Purity of Isolated Human Islets Before Transplantation
Niclauss N., Sgroi A., Morel P., Baertschiger R., Armanet M., Wojtusciszyn A., Parnaud G., Muller Y., Berney T., Bosco D., 2008. Transplantation, 86 (11) pp. 1603-1609.
[DOI][WoS][serval:BIB_0E43F3288C5E]
 
Computer-assisted digital image analysis to quantify the mass and purity of isolated human islets before transplantation
Niclauss N., Sgroi A., Morel P., Baertschiger R., Armanet M., Wojtusciszyn A., Parnaud G., Muller Y., Berney T., Bosco D., 2008. Transplantation, 86 (11) pp. 1603-9.
[DOI][Pmid][serval:BIB_7CAA94248BDC]
 
The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1
Brun T., Hu He K. H., Lupi R., Boehm B., Wojtusciszyn A., Sauter N., Donath M., Marchetti P., Maedler K., Gauthier B. R., 2008. Hum Mol Genet, 17 (4) pp. 478-89.
[DOI][Pmid][serval:BIB_ABB6EEA8A066]
 
The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1
Brun T., He K. H. H., Lupi R., Boehm B., Wojtusciszyn A., Sauter N., Donath M., Marchetti P., Maedler K., Gauthier B. R., 2008. Human Molecular Genetics, 17 (4) pp. 478-489.
[DOI][WoS][serval:BIB_D17C0D8CDC65]
2007
 
Beneficial effects of IL-1ra on islet of Langerhans mass and function in vivo
Wojtusciszyn A., Armanet M., Morel P., Niclauss N., Bosco D., Berney T., 2007/09. Xenotransplantation, 14 (5) pp. 450-450.
[WoS][serval:BIB_69DC0EE59BED]
 
Clinical magnetic resonance imaging of allogeneic islet grafts after iron-labeling
Toso C., Vallee J. P., Ris F., Demuylder-Mischler S., Lepetit-Coiffe M., Armanet M., Wojtusciszyn A., Baertschiger R., Bosco D., Saudek F. et al., 2007/09. Xenotransplantation, 14 (5) pp. 502-503.
[WoS][serval:BIB_26CC31F262B7]
 
Computer-assisted digital image analysis of human islets
Niclauss N., Armanet M., Morel P., Sgroi A., Baertschiger R., Wojtusciszyn A., Berney T., Bosco D., 2007/09. Xenotransplantation, 14 (5) pp. 500-500.
[WoS][serval:BIB_9DAB0733F0F3]
 
IL-1ra increases size and function of islets of Langerhans in vivo
Wojtusciszyn A., Armanet M., Morel P., Bosco D., Berney T., 2007/09. Diabetologia, 50 pp. S186-S186.
[WoS][serval:BIB_B63DB3B66B65]
 
Impact of macrophage migration inhibitory factor on islet engraftment
Toso C., Serre-Beiner V., Morel P., Wojtusciszyn A., Armanet M., Baertschiger R., Bosco D., Shapiro A. W. J., Berney T., 2007/09. Xenotransplantation, 14 (5) pp. 516-516.
[WoS][serval:BIB_A634C832B92E]
 
Pancreatic islet allotransplantation improves the quality of life in brittle type 1 diabetic patients
Milliat-Guittard L., Kessler L., Wojtusciszyn A., Berney T., Badet L., Penfornis F., Thivolet C., Renard E., Bosco D., Baertschiger R. et al., 2007/09. Diabetologia, 50 pp. S202-S202.
[WoS][serval:BIB_3A5E2F09147C]
 
Patients with type 1 diabetes: quality of life after islet of langerhans allotransplantation
Milliat-Guittard L., Benhamou P. Y., Wojtusciszyn A., Berney T., Kessler L., Badet L., Penfornis A., Thivolet C., Renard E., Colin C., 2007/09. Xenotransplantation, 14 (5) pp. 474-475.
[WoS][serval:BIB_25FFF7CE3532]
 
Quality of life improvement in patients with brittle type 1 diabetes after islet of langerhans allotransplantation
Wojtusciszyn A., Kessler L., Milliat-Guittard L., Berney T., Badet L., Penfornis A., Thivolet C., Renard E., Bosco D., Morel P. et al., 2007/09. Transplant International, 20 pp. 166-167.
[WoS][serval:BIB_08BEFC29515D]
 
Results of 105 solitary islet transplantations in 63 Type 1 diabetic patients in the Swiss-French GRAGIL consortium
Berney T., Wojtusciszyn A., Kessler L., Badet L., Penfornis A., Guittard L., Colin C., Renard E., Morel P., Benhamou P. Y., 2007/09. Xenotransplantation, 14 (5) pp. 398-398.
[WoS][serval:BIB_44F04E42971C]
 
Results of 105 solitary islet transplantations in 63 type 1 diabetic patients in the Swiss-French gragil consortium
Berney T., Wojtusciszyn A., Kessler L., Badet L., Penfornis A., Bayle F., Thivolet C., Renoult E., Bosco D., Oberholzer J. et al., 2007/09. Transplant International, 20 pp. 45-45.
[WoS][serval:BIB_74F32796C0ED]
 
Role of TRANCE blockade in murine allogeneic islet transplantation
Wojtusciszyn A., Andres A., Morel P., Charvier S., Armanet M., Buhler L., Bosco D., Berney T., 2007/09. Xenotransplantation, 14 (5) pp. 494-494.
[WoS][serval:BIB_ADCE6024082C]
 
Role of trance pathway blockade in a mouse allogeneic islet transplantation model
Wojtusciszyn A., Andres A., Philippe M., Solange C., Mathieu A., Domenico B., Thierry B., 2007/09. Transplant International, 20 pp. 167-167.
[WoS][serval:BIB_D4A02CD9AFED]
 
Effects of Laminine-5 from the pancreatic island on the activation of macrophages
Armanet M., Wojtusciszyn A., Morel P., Parnaud G., Berney T., Bosco D., 2007/03. Diabetes & Metabolism, 33 pp. S13-S13.
[WoS][serval:BIB_399FD9E14A8A]
 
Improvement of quality of life in the type 1 diabetic after allograft of the pancreatic islands
Wojtusciszyn A., Kessler L., Millat-Guittard L., Berney T., Badet L., Penfornis A., Thivolet C., Dominico B., Baertschiger R., Renard E. et al., 2007/03. Diabetes & Metabolism, 33 pp. S67-S67.
[WoS][serval:BIB_4E91412E96CE]
 
The growth and secretion of Langerhans islands are increased by IL-1ra
Wojtusciszyn A., Armanet M., Morel P., Bosco D., Berney T., 2007/03. Diabetes & Metabolism, 33 pp. S21-S21.
[WoS][serval:BIB_063A09AAAC0F]
 
Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial
Badet L., Benhamou P. Y., Wojtusciszyn A., Baertschiger R., Milliat-Guittard L., Kessler L., Penfornis A., Thivolet C., Renard E., Bosco D. et al., 2007. Transplantation, 84 (1) pp. 89-96.
[DOI][Pmid][serval:BIB_5CD6C4206944]
 
Expectations and strategies regarding islet transplantation: Metabolic data from the GRAGIL 2 trial
Badet L., Benhamou P. Y., Wojtusciszyn A., Baertschiger R., Milliat-Guittard L., Kessler L., Penfornis A., Thivolet C., Renard E., Bosco D. et al., 2007. Transplantation, 84 (1) pp. 89-96.
[DOI][WoS][serval:BIB_CB63AE85A6BC]
2006
 
Assessment of 18F-FDG-leukocyte imaging to monitor rejection after pancreatic islet transplantation
Toso C., Zaidi H., Morel P., Armanet M., Wojtusciszyn A., Mai G., Baertschiger R., Buhler L., Berney T., 2006/11. Transplant Proc, 38 (9) pp. 3033-4.
[DOI][Pmid][serval:BIB_549E3FAF007E]
 
Assessment of F-18-FDG-leukocyte imaging to monitor rejection after pancreatic islet transplantation
Toso C., Zaidi H., Morel P., Armanet M., Wojtusciszyn A., Mai G., Baertschiger R., Buhler L., Berney T., 2006/11. Transplantation Proceedings, 38 (9) pp. 3033-3034.
[DOI][WoS][serval:BIB_21D6BB3CA08E]
 
Human exocrine pancreas-derived mesenchymal stem cells and their potential to differentiate into beta cells
Gonelle-Gispert C., Baertschiger R. M., Morel P., Bosco D., Armanet M., Wojtusciszyn A., Serre-Beinier V., Berney T., Buhler L., 2006/09. Diabetologia, 49 pp. 289-290.
[WoS][serval:BIB_70FED45CB389]
 
Islet extracellular matrix stimulates inflammatory mediator secretion by macrophages
Armanet M., Wojtusciszyn A., Morel P., Baertschiger R., Berney T., Bosco D., 2006/09. Diabetologia, 49 pp. 276-276.
[WoS][serval:BIB_F9160C3F8B53]
 
Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control
Berney T., Mamin A., James Shapiro A. M., Ritz-Laser B., Brulhart M. C., Toso C., Demuylder-Mischler S., Armanet M., Baertschiger R., Wojtusciszyn A. et al., 2006/07. Am J Transplant, 6 (7) pp. 1704-11.
[DOI][Pmid][serval:BIB_2E763640E057]
 
Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control
Berney T., Mamin A., Shapiro A. M. J., Ritz-Laser B., Brulhart M. C., Toso C., Demuylder-Mischler S., Armanet M., Baertschiger R., Wojtusciszyn A. et al., 2006/07. American Journal of Transplantation, 6 (7) pp. 1704-1711.
[DOI][WoS][serval:BIB_90D8B30FDBEB]
 
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol
Toso C., Baertschiger R., Morel P., Bosco D., Armanet M., Wojtusciszyn A., Badet L., Philippe J., Becker C. D., Hadaya K. et al., 2006/05. Am J Transplant, 6 (5 Pt 1) pp. 1049-58.
[DOI][Pmid][serval:BIB_00A7F785F644]
 
Sequential kidney/islet transplantation: Efficacy and safety assessment of a steroid-free immunosuppression protocol
Toso C., Baertschiger R., Morel P., Bosco D., Armanet M., Wojtusciszyn A., Badet L., Philippe J., Becker C. D., Hadaya K. et al., 2006/05. American Journal of Transplantation, 6 (5) pp. 1049-1058.
[DOI][WoS][serval:BIB_6CC45EB5C359]
 
Islet kidney transplantation: insulin-independence is frequent but not at any price
Wojtusciszyn A., Toso C., Morel P. H., Baertschiger R., Armanet M., Buhler L., Bosco D., Berney T., 2006/03. Diabetes & Metabolism, 32 pp. S24-S24.
[WoS][serval:BIB_D13E86B6E77A]
 
The insulin secretion by human beta cells is heterogeneous
Wojtusciszyn A., Armanet M., Morel P. H., Baertschiger R., Berney T., Bosco D., 2006/03. Diabetes & Metabolism, 32 pp. S78-S78.
[WoS][serval:BIB_98C392F9E060]
 
TRANCE: the new way of co-stimulation implicated in the allogenic reject?
Wojtusciszyn A., Andres A., Morel P. H., Charvier S., Armanet M., Baertschiger R., Buhler L., Bosco D., Berney T., 2006/03. Diabetes & Metabolism, 32 pp. S42-S42.
[WoS][serval:BIB_94DAE93C7DD2]
2005
 
A comparison of cold storage solutions for pancreas preservation prior to islet isolation
Wojtusciszyn A., Bosco D., Morel P., Baertschiger R., Armanet M., Kempf M. C., Badet L., Toso C., Berney T., GRAGIL Grp, 2005/10. Transplantation Proceedings, 37 (8) pp. 3396-3397.
[DOI][WoS][serval:BIB_444ACD385447]
 
A comparison of cold storage solutions for pancreas preservation prior to islet isolation
Wojtusciszyn A., Bosco D., Morel P., Baertschiger R., Armanet M., Kempf M. C., Badet L., Toso C., Berney T., 2005/10. Transplant Proc, 37 (8) pp. 3396-7.
[DOI][Pmid][serval:BIB_9BFFC13C0C17]
 
How to select good donors of pancreatic islets? - A difficult task
Baertschiger R. M., Bosco D., Morel P. H., Andres A., Armanet M., Wojtusciszyn A., Berney T. H., 2005/07. British Journal of Surgery, 92 (7) pp. 901-901.
[WoS][serval:BIB_C5C82BA15B2A]
 
Insulin independence in recipients of islet after kidney allogeneic transplantation using a steroid-free protocol
Berney T., Toso C., Baertschiger R., Wojtusciszyn A., Demuylder-Mischler S., Bosco D., Morel P. H., 2005/07. British Journal of Surgery, 92 (7) pp. 904-905.
[WoS][serval:BIB_42DAB19245B1]
 
How to select good donors of pancreatic islets? A difficult task.
Baertschiger R. M., Bosco D., Morel P., Andres A., Armanet M., Wojtusciszyn A., Mathe Z., Bucher P., Pernin N., Charvier S. et al., 2005/05. American Journal of Transplantation, 5 pp. 486-486.
[WoS][serval:BIB_7CFA79F336AB]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University